Health
Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses – News-Medical.Net
Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.
The COVID-19 pandemic has taken a massive toll on human life, with the virus spreading to 188 countries and territories and infecting nearly 17 million individuals. A very significant source of uncertainty in dealing with the pandemic has been the lack of any effective antiviral or vaccine against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) despite strenuous scientific efforts.
Now, a new study published in the preprint server bioRxiv* in July 2020 reports o…
-
General20 hours agoBHP cops $5b value hit on talk of China trade blockade
-
General23 hours agoTotal fire bans in place for large parts of Queensland amid hot, dry conditions
-
Noosa News18 hours agoDally M Awards 2025 live: Best of the NRL and NRLW honoured in Sydney
-
Noosa News24 hours agoPappa Flock Mt Gravatt $10000 Grand Opening